-<ClinicalUseIssue xmlns="http://hl7.org/fhir">
 <!-- ISO name: (id is generated on the fly)  -->
 <id value="SPIOInhaler28mg-d3e1229"/>
 <type value="indication"/>
-<subject>
 </subject>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication  -->
-<indication>
 <!-- ISO name: (fixed value)  -->
-<diseaseSymptomProcedure>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication  -->
-<concept>
-<coding>
 <system value="http://ema.europa.eu/fhir/indicationasdisease-symptom-procedure"/>
 <code value="InfectionPseudomonasaeruginosa"/>
 </coding>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication/IndicationText  -->
 <text value="SPIO Inhaler is indicated for the suppressive therapy of chronic pulmonary infection due to Pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis."/>
 </concept>
 </diseaseSymptomProcedure>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication/DiseaseStatus  -->
-<diseaseStatus>
-<concept>
-<coding>
 <system value="http://ema.europa.eu/fhir/diseasestatus"/>
 <code value="chronic"/>
 </coding>
 </concept>
 </diseaseStatus>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication/Comorbidity  -->
-<comorbidity>
-<concept>
-<coding>
 <system value="http://ema.europa.eu/fhir/comorbidity"/>
 <code value="cysticfibrosis"/>
 </coding>
 </concept>
 </comorbidity>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication/IntendedEffect  -->
-<intendedEffect>
-<concept>
-<coding>
 <system value="http://ema.europa.eu/fhir/intendedeffect"/>
 <code value="suppresivetherapy"/>
 </coding>
 </concept>
 </intendedEffect>
 </indication>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication/PopulationSpecifics  -->
-<population>
 <!-- ISO name: (fixed value)  -->
-<ageRange>
 <!-- ISO name: /MedicinalProduct/TherapeuticIndication/PopulationSpecifics/AgeRangeLow  -->
-<low>
 <value value="6"/>
 <unit value="a"/>
 </low>
 </ageRange>
 </population>
 </ClinicalUseIssue>